Research
Schrödinger (SDGR) Stock Analysis & Research
- Latest rating
- Sell
- Latest report
- Aug 17, 2026
- Reports
- 1
- Sector
- Healthcare
Schrodinger (SDGR) develops and licenses physics-based computational software for molecule discovery and optimization, and also runs collaborative and proprietary drug discovery programs on the same platform. In 2025, software revenue was $199.5M and drug discovery revenue was $56.4M.



